The First Case of COVID-19 Reinfection in Duhok City, Kurdistan Region of Iraq: A Case Report

N. Hussein, Dildar H. Musa, I. Naqid, Zana Sidiq M.Saleem, Nashwan Ibrahim
{"title":"The First Case of COVID-19 Reinfection in Duhok City, Kurdistan Region of Iraq: A Case Report","authors":"N. Hussein, Dildar H. Musa, I. Naqid, Zana Sidiq M.Saleem, Nashwan Ibrahim","doi":"10.5812/jkums.111454","DOIUrl":null,"url":null,"abstract":"Introduction: Coronavirus disease (COVID-19) causes a severe acute respiratory syndrome and is known as coronavirus 2 (SARS-CoV-2), which was first discovered in December, 2019 in Wuhan, China. The question of whether the COVID-19 patients that recover from the disease acquire immunity or are still susceptible to reinfection remains unanswered. Case Presentation: In this study, we presented the case of a 46-year-old male who recovered from the first round of COVID-19 infection. After symptom resolution, two consecutives negative real-time reverse transcription-polymerase chain reaction (RT-PCR) tests confirmed the negativity of the patient. Seven weeks after the first infection, the patient presented with fever and dry cough, and the infection was confirmed using real-time RT-PCR. The reinfection was associated with more severe symptoms, which required antiviral treatment. Conclusions: Our study indicated the possibility of COVID-19 reinfection. If the occurrence of reinfections is confirmed, it may implicate changes in the vaccine and community-based disease prevention strategies. Further studies are required to confirm the possibility of COVID-19 reinfection.","PeriodicalId":16201,"journal":{"name":"Journal of Kermanshah University of Medical Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Kermanshah University of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/jkums.111454","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

Abstract

Introduction: Coronavirus disease (COVID-19) causes a severe acute respiratory syndrome and is known as coronavirus 2 (SARS-CoV-2), which was first discovered in December, 2019 in Wuhan, China. The question of whether the COVID-19 patients that recover from the disease acquire immunity or are still susceptible to reinfection remains unanswered. Case Presentation: In this study, we presented the case of a 46-year-old male who recovered from the first round of COVID-19 infection. After symptom resolution, two consecutives negative real-time reverse transcription-polymerase chain reaction (RT-PCR) tests confirmed the negativity of the patient. Seven weeks after the first infection, the patient presented with fever and dry cough, and the infection was confirmed using real-time RT-PCR. The reinfection was associated with more severe symptoms, which required antiviral treatment. Conclusions: Our study indicated the possibility of COVID-19 reinfection. If the occurrence of reinfections is confirmed, it may implicate changes in the vaccine and community-based disease prevention strategies. Further studies are required to confirm the possibility of COVID-19 reinfection.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊拉克库尔德斯坦地区杜霍克市首例COVID-19再感染病例报告
简介:冠状病毒病(COVID-19)引起严重急性呼吸系统综合征,被称为冠状病毒2 (SARS-CoV-2),于2019年12月在中国武汉首次发现。COVID-19患者从疾病中恢复后是否获得免疫力或仍然容易再次感染的问题仍然没有答案。病例介绍:在本研究中,我们报告了一名46岁的男性,他从第一轮COVID-19感染中康复。症状缓解后,连续两次实时逆转录聚合酶链反应(RT-PCR)检测均为阴性,证实患者为阴性。首次感染后7周,患者出现发热、干咳等症状,采用实时RT-PCR法确诊感染。再次感染与更严重的症状相关,需要抗病毒治疗。结论:我们的研究显示了COVID-19再感染的可能性。如果确认再次感染的发生,可能会涉及疫苗和社区疾病预防战略的变化。需要进一步研究以确认COVID-19再感染的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
How Effective Are In-Hospital Training Workshops on Infection Control for Physicians? First Report in Iran Capability of Artificial Intelligence in Enhancing Neonatal Care Quality in Iran Medicinal Chemistry is Shaping the World of Therapy Search Trends for Micronutrients on Google Trends in Iran for Historical Effect of the COVID-19 Pandemic: A Ecological Study The Effect of Quadruple Therapy Plus Probiotics on Helicobacter Pylori Eradication and Antibiotic-Associated Side Effects: A Randomized Placebo-Controlled Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1